Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Systagenix Wound Management announces head of EMEA to boost international market

This article was originally published in Clinica

Executive Summary

Systagenix Wound Management (London, UK), formerly Ethicon's wound care division, has appointed Frank DiLazzaro as president of Europe, Middle East and Africa (EMEA). His remit is to strengthen the current regional management teams and significantly boost the uptake of Systagenix's products in these markets. Mr DiLazzaro has a strong background in wound care products. He is credited with playing a key role in the transformation of the negative pressure wound therapy business at Kinetic Concepts. His experience in both public and private equity settings and his academic background in economics are expected to be valuable skills in helping Systagenix build its international market.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel